Title:
肺癌を検出するためのバイオマーカーパネル
Document Type and Number:
Japanese Patent JP7311659
Kind Code:
B2
Abstract:
A biomarker panel for a urine test for detecting lung cancer detects a biomarker selected from the group of biomarkers consisting of DMA, C5:1, C10:1, ADMA, C5-OH, SDMA, and kynurenine, or a combination thereof. A biomarker panel for a serum test for detecting lung cancer detects a biomarker selected from the group of biomarkers consisting of valine, arginine, ornithine, methionine, spermidine, spermine, diacetylspermine, C10:2, PC aa C32:2, PC ae C36:0, and PC ae C44:5; and lysoPC a C18:2, or a combination thereof.
More Like This:
Inventors:
Bux, Rashid
Sitter, Daniel
Sitter, Daniel
Application Number:
JP2022032288A
Publication Date:
July 19, 2023
Filing Date:
March 03, 2022
Export Citation:
Assignee:
BIOMARK CANCER SYSTEMS INC.
International Classes:
G01N33/82; G01N33/493; G01N33/68; G01N33/92
Domestic Patent References:
| JP2012233902A | ||||
| JP2012520463A |
Foreign References:
| WO2007076439A2 | ||||
| WO2015088947A1 | ||||
| WO2014139025A1 |
Other References:
WU, Q. et al.,Urinary metabolomic study of non-small cell lung carcinoma based on ultra high performance liquid chromatography coupled with quadrupole time-of-flight mass spectrometry,JOURNAL OF SEPARATION SCIENCE,Vol.37/No.14,2014年04月26日,p.1728-1735
Attorney, Agent or Firm:
Hitoshi Shimbo